Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dirk-Jan Opstelten"'
Autor:
Raymond Pieters, Ronald van Ree, Els van Hoffen, André C. Knulst, Hans J. M. Warmenhoven, Hanneke P. M. van der Kleij, Stef J. Koppelman, Dirk Jan Opstelten, Serge A. Versteeg, Stephen C. Dreskin, Joost J. Smit
Publikováno v:
Allergy, 74(5), 986. Wiley-Blackwell
Allergy, 74(5), 986-995. Wiley-Blackwell
Allergy, 74(5), 986-995. Wiley-Blackwell
Background: Peanuts are most responsible for food-induced anaphylaxis in adults in developed countries. An effective and safe immunotherapy is urgently needed. The aim of this study was to investigate the immunogenicity, allergenicity, and immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeca4a8ae0dabb744ee428f9ddb4c917
https://dspace.library.uu.nl/handle/1874/391827
https://dspace.library.uu.nl/handle/1874/391827
Autor:
J. D. Boot, R. van Ree, Dirk-Jan Opstelten, E van Twuijver, Oliver Pfaar, Zuzana Diamant, P. Panzner, Piotr Kuna, Ludger Klimek
Publikováno v:
Allergy, 71(1), 99-107. Wiley-Blackwell
Allergy
Allergy
Background: Sublingual immunotherapy (SLIT) is a potential efficacious and safe treatment option for patients with respiratory, IgE-mediated allergic diseases. A combined tolerability, dose-finding study with a sublingual liquid birch pollen preparat
Autor:
André C. Knulst, H. P. M. van der Kleij, Edward F. Knol, Dirk Jan Opstelten, W. A. van Doorn, Stef J. Koppelman, C. F. den Hartog Jager, E. van Hoffen
Publikováno v:
Clinical & Experimental Allergy. 44:1558-1566
SummaryBackground Specific immunotherapy for peanut allergy is associated with significant side-effects. Chemically modified allergens may provide a safer alternative. Objective This study aimed to analyse the immunogenicity and allergenicity of modi
Autor:
Lara Gouveia, Ronald van Ree, Dirk-Jan Opstelten, Derya Canbaz, Leonie S. van Rijt, Hanneke P. M. van der Kleij, A. Logiantara
Publikováno v:
International archives of allergy and immunology, 165(2), 128-139. S. Karger AG
Background: Suppression of Th2 cytokine production by allergen-specific Th2 cells is considered to be critical for the suppression of allergic symptoms by subcutaneous immunotherapy. The aim of this study was to develop a mouse model for birch pollen
Autor:
Edwin H. Kim, Scott H. Sicherer, Robert A. Wood, Stephen A. Tilles, Iftikhar Hussain, Erika G. Gonzalez-Reyes, Peter Couroux, Annemie Narkus, Dirk-Jan Opstelten, Andrey S. Larionov, Ioanna Stavrakaki
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB243
Autor:
Ton Logtenberg, Nathalie Kroos, Sven van der Kraats, Patrick Van Berkel, Dirk-Jan Opstelten, Shirley Smits, Abraham Bout, David Halford Ashton Jones, Andre Vooys, Bart A. Van Montfort, Regina Anema, Jan Schouten, Fija M. Lagerwerf, Kirsten Brouwer, Esmeralda van der Helm
Publikováno v:
Biotechnology Progress. 19:163-168
The number of therapeutic monoclonal antibodies in production is expected to rise rapidly in the next few years. As a result, there is much focus on the optimization of antibody expression platforms. Several issues are important including the speed o
Autor:
Shoshan Knaän-Shanzer, Antoine A.F. de Vries, Brain T. H. Maassen, Josephine M. Janssen, Evert Heemskerk, Ietje van der Velde, Dirk-Jan Opstelten, Dinko Valerio, Manuel A F V Gonçalves
Publikováno v:
Journal of Virology. 76:10734-10744
Effective gene therapy is dependent on safe gene delivery vehicles that can achieve efficient transduction and sustained transgene expression. We are developing a hybrid viral vector system that combines in a single particle the large cloning capacit
Autor:
Anja Pahlow Mose, Line Kring Tannert, Pieter-Jan de Kam, Carsten Bindslev-Jensen, Esther van Twuijver, Rachid El Galta, Dirk-Jan Opstelten, Diderik Boot Boot
Publikováno v:
Journal of Allergy and Clinical Immunology. 139:AB191
Autor:
Adriano Mari, Alberto Martínez, Claudio Nicoletti, Laurian Zuidmeer-Jongejan, Enrico Scala, Anna Lewandowska-Polak, Hans Huber, Rudolf Valenta, Serge A. Versteeg, Birgit Linhart, Heidi J. Schnoor, Paula Garosi, George A. Stavroulakis, Marek L. Kowalski, Nikos Papadopoulos, Ronald van Ree, Juan A. Asturias, Bettina M. Jensen, Angela Neubauer, Bernard Maillere, Clare Mills, Lars K. Poulsen, Ines Swoboda, Frank Stolz, Rob Van Den Hout, Montserrat Fernandez-Rivas, Marianne Witten, Joyce I. Boye, Stef J. Koppelman, Neil M. Rigby, Rosa Ferrara, Michael Clausen, Carsten Bindslev-Jensen, Antonio Portolés, Lars Blom, Dirk Jan Opstelten, Sigurveig T. Sigurdardottir
Publikováno v:
Zuidmeer-Jongejan, L, Fernandez-Rivas, M, Poulsen, L K, Neubauer, A, Asturias, J, Blom, L, Boye, J, Bindslev-Jensen, C, Clausen, M, Ferrara, R, Garosi, P, Huber, H, Jensen, B M, Koppelman, S, Kowalski, M L, Lewandowska-Polak, A, Linhart, B, Maillere, B, Mari, A, Martinez, A, Mills, C E, Nicoletti, C, Opstelten, D-J, Papadopoulos, N G, Portoles, A, Rigby, N, Scala, E, Schnoor, H J, Sigursdottir, S, Stavroulakis, G, Stolz, F, Swoboda, I, Valenta, R, van den Hout, R, Versteeg, S A, Witten, M & van Ree, R 2012, ' FAST : Towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies ', Clinical and Translational Allergy, vol. 2, no. 1, pp. 5 . https://doi.org/10.1186/2045-7022-2-5
Clinical and Translational Allergy; Vol 2
Clinical and translational allergy, 2(1). BioMed Central
Clinical and Translational Allergy
Clinical and Translational Allergy, Vol 2, Iss 1, p 5 (2012)
Clinical and Translational Allergy; Vol 2
Clinical and translational allergy, 2(1). BioMed Central
Clinical and Translational Allergy
Clinical and Translational Allergy, Vol 2, Iss 1, p 5 (2012)
The FAST project (Food Allergy Specific Immunotherapy) aims at the development of safe and effective treatment of food allergies, targeting prevalent, persistent and severe allergy to fish and peach. Classical allergen-specific immunotherapy (SIT), u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84006fcf6dd1c6aa892a44e1f944e5b6
https://portal.findresearcher.sdu.dk/da/publications/bc7630fb-5496-4745-8ef0-a8e076410a91
https://portal.findresearcher.sdu.dk/da/publications/bc7630fb-5496-4745-8ef0-a8e076410a91
Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells
Autor:
Ghaith Bakdash, Dirk-Jan Opstelten, Marcel B. M. Teunissen, Darya S. Sibiryak, Martien L. Kapsenberg, Hanneke P. M. van der Kleij, Esther C. de Jong, Toni M.M. van Capel, Angelic M. G. van der Aar
Publikováno v:
Journal of allergy and clinical immunology, 127(6), 1532-U334. Mosby Inc.
Background: The vitamin D metabolite 1,25(OH) 2D3 (VitD3) is a potent immunosuppressive drug and, among others, is used for topical treatment of psoriasis. A proposed mechanism of VitD3-mediated suppression is priming of dendritic cells (DCs) to indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccd5aa4a83d55a81944dd6e2226879a
https://pure.amc.nl/en/publications/vitamin-d3-targets-epidermal-and-dermal-dendritic-cells-for-induction-of-distinct-regulatory-t-cells(aa687fd0-c2a8-4aa5-a3b5-73a40cfc441f).html
https://pure.amc.nl/en/publications/vitamin-d3-targets-epidermal-and-dermal-dendritic-cells-for-induction-of-distinct-regulatory-t-cells(aa687fd0-c2a8-4aa5-a3b5-73a40cfc441f).html